News
Jones Healthcare Group Invests in New High-Performance Uhlmann Blister...
Jones Healthcare Group, a market leader in advanced packaging and medication dispensing solutions, announces a significant investment in its packaging services offering including a new,...
News
US Govt. Invests $143M to Scale Up SiO2’s Primary...
SiO2 Materials Science, a privately-owned U.S. advanced materials science corporation introducing breakthrough disruptive technology for packaging biological pharmaceuticals and vaccines, has unveiled a $143 million...
News
Berkshire Sterile Manufacturing lands financing for major expansion
Berkshire Sterile Manufacturing took another step toward an ambitious $20 million expansion plan when it recently closed on the majority of the project’s financing.
The firm,...
News
UCB Acquires Engage Therapeutics for $125M
UCB announced the acquisition of Engage Therapeutics, Inc., a clinical-stage pharmaceutical company developing Staccato®Alprazolam for the rapid termination of an active epileptic seizure, for US$...
News
Lonza to Host New Webinar – “The Compendia are...
On 16 June, Lonza will host a free 60-minute webinar on the latest regulatory developments surrounding the use of the recombinant Factor C (rFC) assay...
News
Albumedix Announces Appointment of Gregor Kawaletz as Chief Commercial...
Albumedix Ltd., the world leader in recombinant human albumin (rAlb), announced the strengthening of its Executive Leadership with the appointment of Gregor Kawaletz as Chief...
News
Sygnature expands capabilities with acquisition of Alderley Oncology
Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical services company, is further strengthening its oncology and immuno-oncology capabilities with the acquisition of Alderley...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.